IZUMO2
gene geneOn this page
Also known as MGC33947SCRL
Summary
IZUMO2 (IZUMO family member 2, HGNC:28518) is a protein-coding gene on chromosome 19q13.33, encoding Izumo sperm-egg fusion protein 2 (Q6UXV1).
Predicted to be located in membrane.
Source: NCBI Gene 126123 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_152358
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28518 |
| Approved symbol | IZUMO2 |
| Name | IZUMO family member 2 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33947, SCRL |
| Ensembl gene | ENSG00000161652 |
| Ensembl biotype | protein_coding |
| OMIM | 618895 |
| Entrez | 126123 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 2 nonsense_mediated_decay
ENST00000293405, ENST00000486050, ENST00000594854, ENST00000600293, ENST00000916628
RefSeq mRNA: 2 — MANE Select: NM_152358
NM_001321449, NM_152358
CCDS: CCDS12792
Canonical transcript exons
ENST00000293405 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001059493 | 50162739 | 50162813 |
| ENSE00001751544 | 50152548 | 50152651 |
| ENSE00001918580 | 50162963 | 50163281 |
| ENSE00003559386 | 50158268 | 50158348 |
| ENSE00003578361 | 50154600 | 50154726 |
| ENSE00003672786 | 50159230 | 50159250 |
| ENSE00003676949 | 50159494 | 50159580 |
Expression profiles
Bgee: expression breadth broad, 82 present calls, max score 93.99.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0909 / max 38.7933, expressed in 38 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182142 | 0.0629 | 33 |
| 182141 | 0.0280 | 5 |
Top tissues by expression
208 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 93.99 | gold quality |
| right testis | UBERON:0004534 | 93.89 | gold quality |
| sperm | CL:0000019 | 93.14 | gold quality |
| testis | UBERON:0000473 | 90.51 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.37 | gold quality |
| adult organism | UBERON:0007023 | 71.85 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.25 | gold quality |
| upper arm skin | UBERON:0004263 | 64.25 | gold quality |
| buccal mucosa cell | CL:0002336 | 63.83 | gold quality |
| secondary oocyte | CL:0000655 | 59.46 | gold quality |
| tibialis anterior | UBERON:0001385 | 58.96 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 57.45 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 57.34 | gold quality |
| parotid gland | UBERON:0001831 | 56.48 | gold quality |
| vena cava | UBERON:0004087 | 55.42 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.84 | gold quality |
| superficial temporal artery | UBERON:0001614 | 54.80 | gold quality |
| cortical plate | UBERON:0005343 | 54.75 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| pericardium | UBERON:0002407 | 53.72 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.62 | gold quality |
| deltoid | UBERON:0001476 | 52.42 | gold quality |
| pancreatic ductal cell | CL:0002079 | 51.51 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 51.08 | gold quality |
| lower lobe of lung | UBERON:0008949 | 50.52 | silver quality |
| myocardium | UBERON:0002349 | 50.46 | gold quality |
| oocyte | CL:0000023 | 47.84 | gold quality |
| quadriceps femoris | UBERON:0001377 | 47.81 | gold quality |
| trachea | UBERON:0003126 | 47.41 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.39 |
| E-MTAB-7303 | no | 7.25 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Expression of IZUMO2 in colorectal cancer in association with clinicopathological features. (PMID:38484656)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Izumo2 | ENSMUSG00000066500 |
| rattus_norvegicus | Izumo2 | ENSRNOG00000065701 |
Protein
Protein identifiers
Izumo sperm-egg fusion protein 2 — Q6UXV1 (reviewed: Q6UXV1)
All UniProt accessions (4): Q6UXV1, M0QXA9, M0QZG1, M0R2L8
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Miscellaneous. Izumo is the name of a Japanese shrine to marriage.
Similarity. Belongs to the Izumo family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6UXV1-1 | 1 | yes |
| Q6UXV1-2 | 2 |
RefSeq proteins (2): NP_001308378, NP_689571* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029389 | IZUMO | Family |
| IPR042920 | IZUMO2 | Family |
Pfam: PF15005
UniProt features (8 total): topological domain 2, signal peptide 1, chain 1, transmembrane region 1, glycosylation site 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UXV1-F1 | 86.82 | 0.68 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 91
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-1300645 | Acrosome Reaction and Sperm:Oocyte Membrane Binding |
| R-HSA-1187000 | Fertilization |
| R-HSA-1474165 | Reproduction |
MSigDB gene sets: 11 (showing top):
REACTOME_FERTILIZATION, REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING, REACTOME_REPRODUCTION, ZIM3_TARGET_GENES, ZNF596_TARGET_GENES, GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN, GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN, chr19q13, GSE2585_CTEC_VS_THYMIC_DC_UP, GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP, GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Fertilization | 1 |
| Reproduction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
248 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IZUMO2 | IZUMO3 | Q5VZ72 | 843 |
| IZUMO2 | IZUMO4 | Q1ZYL8 | 825 |
| IZUMO2 | IZUMO1 | Q8IYV9 | 726 |
| IZUMO2 | ISOC2 | Q96AB3 | 574 |
| IZUMO2 | ADAM32 | Q8TC27 | 560 |
| IZUMO2 | ADAM2 | P78326 | 528 |
| IZUMO2 | OR4N5 | Q8IXE1 | 525 |
| IZUMO2 | SPACA4 | Q8TDM5 | 519 |
| IZUMO2 | OR4K14 | Q8NGD5 | 507 |
| IZUMO2 | RASIP1 | Q5U651 | 471 |
| IZUMO2 | GLIPR1L1 | Q6UWM5 | 460 |
| IZUMO2 | UNC50 | Q53HI1 | 447 |
| IZUMO2 | ZNF556 | Q9HAH1 | 446 |
| IZUMO2 | SPACA1 | Q9HBV2 | 392 |
| IZUMO2 | TEKT5 | Q96M29 | 372 |
IntAct
0 interactions, top by confidence:
BioGRID (1): IZUMO2 (Two-hybrid)
ESM2 similar proteins: A0A1B0GUA7, A0A3Q1LRJ2, A2T6Z6, E9Q8Q8, O46673, O77049, O88823, P01588, P07865, P22301, P29676, P43480, P46651, P48411, P51496, P51497, P51746, P55029, P79338, Q0Z972, Q25BC1, Q28374, Q28C41, Q2PE73, Q3KNT9, Q4VK74, Q5Q0V6, Q5ZJY9, Q6A2H4, Q6AY06, Q6H8S9, Q6H8T0, Q6H8T1, Q6H8T2, Q6UXV1, Q865X4, Q8BGT0, Q8CGK6, Q8CJ70, Q8IU54
Diamond homologs: A6PWV3, A6QL94, Q5VZ72, Q6UXV1, Q9DA16
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
917 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:50158262:GCTTA:G | donor_loss | 1.0000 |
| 19:50158263:CTTAC:C | donor_loss | 1.0000 |
| 19:50158265:TA:T | donor_loss | 1.0000 |
| 19:50158266:ACC:A | donor_loss | 1.0000 |
| 19:50158267:C:CG | donor_loss | 1.0000 |
| 19:50158346:AGCC:A | acceptor_loss | 1.0000 |
| 19:50158347:GCCT:G | acceptor_loss | 1.0000 |
| 19:50158348:CCTA:C | acceptor_loss | 1.0000 |
| 19:50158349:CT:C | acceptor_loss | 1.0000 |
| 19:50158350:T:A | acceptor_loss | 1.0000 |
| 19:50159521:T:A | donor_gain | 1.0000 |
| 19:50159529:T:TA | donor_gain | 1.0000 |
| 19:50162812:CT:C | acceptor_gain | 1.0000 |
| 19:50162814:C:CC | acceptor_gain | 1.0000 |
| 19:50162959:GCAC:G | donor_loss | 1.0000 |
| 19:50162962:C:CA | donor_loss | 1.0000 |
| 19:50162962:CCCA:C | donor_gain | 1.0000 |
| 19:50162965:A:AC | donor_gain | 1.0000 |
| 19:50162966:C:CC | donor_gain | 1.0000 |
| 19:50162969:T:A | donor_gain | 1.0000 |
| 19:50162984:T:A | donor_gain | 1.0000 |
| 19:50162993:AGT:A | donor_gain | 1.0000 |
| 19:50162993:AGTC:A | donor_gain | 1.0000 |
| 19:50158266:A:AC | donor_gain | 0.9900 |
| 19:50158267:C:CC | donor_gain | 0.9900 |
| 19:50158344:CAAGC:C | acceptor_gain | 0.9900 |
| 19:50158347:GC:G | acceptor_gain | 0.9900 |
| 19:50158348:CC:C | acceptor_gain | 0.9900 |
| 19:50158349:C:CC | acceptor_gain | 0.9900 |
| 19:50162809:TGTCT:T | acceptor_gain | 0.9900 |
AlphaMissense
1418 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:50162976:A:C | F73L | 0.979 |
| 19:50162976:A:T | F73L | 0.979 |
| 19:50162978:A:G | F73L | 0.979 |
| 19:50158273:C:G | C164S | 0.967 |
| 19:50158274:A:T | C164S | 0.967 |
| 19:50158322:A:G | C148R | 0.966 |
| 19:50163001:A:C | F65C | 0.966 |
| 19:50159247:C:T | C133Y | 0.964 |
| 19:50158272:G:C | C164W | 0.963 |
| 19:50159247:C:G | C133S | 0.961 |
| 19:50159248:A:T | C133S | 0.961 |
| 19:50159546:C:A | R114S | 0.960 |
| 19:50159546:C:G | R114S | 0.960 |
| 19:50159522:C:A | K122N | 0.959 |
| 19:50159522:C:G | K122N | 0.959 |
| 19:50159559:A:G | L110P | 0.959 |
| 19:50163003:G:C | F64L | 0.958 |
| 19:50163003:G:T | F64L | 0.958 |
| 19:50163005:A:G | F64L | 0.958 |
| 19:50158273:C:T | C164Y | 0.956 |
| 19:50158321:C:G | C148S | 0.956 |
| 19:50158322:A:T | C148S | 0.956 |
| 19:50163063:G:C | F44L | 0.956 |
| 19:50163063:G:T | F44L | 0.956 |
| 19:50163065:A:G | F44L | 0.956 |
| 19:50163064:A:C | F44C | 0.955 |
| 19:50158274:A:G | C164R | 0.953 |
| 19:50159232:C:G | C138S | 0.953 |
| 19:50159233:A:T | C138S | 0.953 |
| 19:50163134:A:G | C21R | 0.952 |
dbSNP variants (sampled 300 via entrez): RS1000234823 (19:50163190 G>A), RS1000291839 (19:50156871 C>T), RS1000349301 (19:50160544 G>A), RS1000524192 (19:50154421 G>A), RS1000992310 (19:50160784 C>A,T), RS1001434997 (19:50155689 T>G), RS1002082787 (19:50153775 A>C,T), RS1002502064 (19:50160448 T>C), RS1002723444 (19:50164789 T>G), RS1002994364 (19:50152489 G>A), RS1003101295 (19:50159010 T>C), RS1003487882 (19:50165116 A>G), RS1004217555 (19:50157909 A>AT), RS1004375298 (19:50154794 A>C,G), RS1004689549 (19:50163738 G>A,C,T)
Disease associations
OMIM: gene MIM:618895 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| sodium arsenite | increases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation, increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.